Depomed Inc

Visual Financials
Company Name: Depomed Inc
Ticker Symbol: DEPO
CIK Number: 0001005201
WWW Address: http://www.depomed.com
CEO: Arthur J. Higgins
No. of Employees: 490
Common Issue Type: CS
Business Description:DepoMed, Inc. is a specialty pharmaceutical company that focuses on pain and other conditions and diseases of the central nervous system. Its products line encompasses Gralise, Zipsor, Glumetza, Janumet XR, and Proquin XR, among others.

 
Industry Information: DRUGS - Drug Manufacturers - Other [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 7.3 Unchanged 0.0 7.25 7.43  7.42 7.09 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 466.6 63.9 0.00 -1.63 0.00 0.0 0.0 9.48 - 4.31
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close7.31$
PE Ratio - LTM0.0
Market Capitalisation466.6mil
Latest Shares Outstanding63.9mil
Earnings pS (EPS)-1.63$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee2,239,553$
Effective Tax Rate0.0%
Float52.8mil
Float as % of Shares Outstanding0.8%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.50%
Research & Devlopment (R&D) as % of Revenue0.10%
Gross Profit Margin80.9%
EBITDA Margin19.7%
Pre-Tax Profit Margin0.0%
Assets Turnover33.6%
Return on Assets (ROA)-9.1%
Return on Equity (ROE)-48.8%
Return on Capital Invested (ROCI)-3.3%
Current Ratio0.7
Leverage Ratio (Assets/Equity)6.1
Interest Cover-0.4
Total Debt/Equity (Gearing Ratio)3.70
LT Debt/Total Capital76.0%
Working Capital pS-1.25$
Cash pS0.00$
Book-Value pS2.99$
Tangible Book-Value pS-9.77$
Cash Flow pS0.16$
Free Cash Flow pS0.14$
KEY FIGURES (LTM): Price info
Price/Book Ratio2.41
Price/Tangible Book Ratio0.00
Price/Cash Flow45.9
Price/Free Cash Flow50.5
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week----23.0-221,338,9411,800,192
4 Weeks9.486.928.27-13.2-141,010,61321,222,876
13 Weeks9.485.957.36-2.4-71,146,71773,389,925
26 Weeks9.485.886.746.51,164,658147,911,591
52 Weeks9.484.316.1516.721,238,537312,111,421
YTD9.485.88--15.8-211,120,912174,862,410
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
7.418.127.657.177.160.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.330.3-0.01
Income0.0
Dividend0.0
Capital SpendingNA
R&D-12.12NA-19.60
Normalized Inc.0.00NA0.00
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %55.555.5-31.7
Earnings %0.00.0-100.0
EPS %0.00.0-100.0
EPS $0.060.06-1.79
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio-7.68
Current Ratio0.7
Quick Ratio (Acid Test)0.6
Liquidity Ratio (Cash)0.82
Receivables Turnover4.4
Average Collection Period82
Working Capital/Equity0.0
Working Capital pS-1.26
Cash-Flow pS0.99
Free Cash-Flow pS0.98
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.39
Financial Leverage Ratio (Assets/Equity)3.7
Debt Ratio60.3
Total Debt/Equity (Gearing Ratio)3.70
LT Debt/Equity3.21
LT Debt/Capital Invested70.1
LT Debt/Total Liabilities86.8
Interest Cover-0.4
Interest/Capital Invested10.10
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.44
Current P/E Ratio - LTM0.00
Enterprise Value (EV)/EBITDA14.32
Enterprise Value (EV)/Free Cash Flow9.55
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM2.41
Price/Cash Flow Ratio45.9
Price/Free Cash Flow Ratio - LTM50.5
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM0.0
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio0.0
5-Y Low P/E Ratio0.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E
P/E as % of Industry Group0.0
P/E as % of Sector Segment0.0
Current 12 Month Normalized P/E Ratio - LTM0.0
PER SHARE FIGURES
LT Debt pS10.25
Current Liabilities pS5.85
Tangible Book Value pS - LTM-9.77
Book Value pS - LTM2.99
Capital Invested pS12.46
Cash pS - LTM0.00
Cash Flow pS - LTM0.16
Free Cash Flow pS - LTM0.14
Earnings pS (EPS)-1.63
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin16.15
Free Cash Flow Margin 5YEAR AVG12.54
Net Profit Margin-0.2
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity2.25
Return on Equity (ROE)-0.5
Return on Equity (ROE) - 5YEAR AVRG.0.0
Capital Invested Productivity0.48
Return on Capital Invested (ROCI)0.1
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.1
Assets Productivity0.30
Return on Assets (ROA)-0.1
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin80.9
Gross Profit Margin - 5YEAR AVRG.0.9
EBITDA Margin - LTM19.7
EBIT Margin - LTM-8.0
Pre-Tax Profit Margin0.0
Pre-Tax Profit Margin - 5YEAR AVRG.0.0
Effective Tax Rate-0.1
Effective Tax Rate - 5YEAR AVRG.270.2
EFFICIENCY RATIOS
Cash Conversion Cycle869,142
Revenue per Employee2,239,553
Net Income per Employee
Average Collection Period869,142
Receivables Turnover4.4
Day's Inventory Turnover Ratio
Inventory Turnover5.6
Inventory/Sales3.4
Accounts Payble/Sales25.54
Assets/Revenue3.33
Net Working Capital Turnover-4.78
Fixed Assets Turnover0.47
Total Assets Turnover0.3
Revenue per $ Cash3.00
Revenue per $ Plant29.23
Revenue per $ Common Equity2.25
Revenue per $ Capital Invested0.48
Selling, General & Adm/tive (SG&A) as % of Revenue51.4
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue10.1
R&D Expense as % of Revenue - 5YEAR AVRG.10.1

  


Your Recent History
NASDAQ
DEPO
Depomed, I..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.